Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies
Transfusion · 2025
DOI: 10.1111/trf.18102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Charlotte Muret und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, Epalinges, Switzerland. Hauptthemen laut MEDLINE: Blood Platelets, Blood Preservation, Biotinylation. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Swiss Red Cross humanitarian foundation, Jacques und Gloria Gossweiler-Stiftung.
Abstract (Originalsprache)
Background
Production of platelet concentrates (PCs) involves several steps that significantly affect platelet behavior. To gain a deeper understanding of how storage conditions impact donor platelet recirculation and functionality post‐transfusion, ex vivo platelet labeling is a feasible approach. However, before pursuing clinical investigations of platelet recirculation and function in humans, we aimed to determine the effects of pathogen inactivation technology (PIT) and storage conditions (4°C vs. room temperature [RT]) on phenotype and function of biotinylated platelets compared to conventional PIT PCs for transfusion.
Methods
Nine PCs were prepared in 61% additive solution from 45 buffy coats (five buffy coats each). A pool‐and‐split of three units was used to prepare three equivalent PCs: two labeled with biotin and stored at RT or 4°C, and one without labeling and stored at RT. All PCs were then treated by PIT (amotosalen/UVA) and stored for 14 days. Labeling efficiency, platelet concentration, metabolic parameters, aggregation response (ADP, collagen, co‐aggregation with epinephrine), and platelet phenotype (CD42b, CD62‐P, phosphatidylserine) at the basal stage and upon stimulation (ADP or TRAP‐6) were performed.
Results
Labeling efficiency of PIT and 4°C PCs was stable over 14 days of storage. Differences in platelet function and phenotype were mainly due to the storage temperature and not the biotinylation process. Phenotypes at baseline or after stimulation were equivalent in biotin‐positive and biotin‐negative platelets.
Conclusion
Biotin‐labeled platelets can effectively enable investigation of the effects of PIT and storage temperature for clinical studies. This method shows great potential for improving platelet transfusion knowledge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, Epalinges, Switzerland.
- Laboratoire de Préparation Cellulaire et d'Analyses, Transfusion Interrégionale CRS, Epalinges, Switzerland.
- Division of Hematology and Central Hematology Laboratory, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
ORCID-Profile: Charlotte Muret, Debora Bertaggia Calderara, Michel Prudent
Förderung
- Swiss Red Cross humanitarian foundation
- Jacques und Gloria Gossweiler-Stiftung
Zitieren
APA
Muret, C., Crettaz, D., Martin, A., Aliotta, A., Bertaggia Calderara, D., Alberio, L., & Prudent, M. (2025). Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies. Transfusion. https://doi.org/10.1111/trf.18102
Vancouver
Muret C, Crettaz D, Martin A, Aliotta A, Bertaggia Calderara D, Alberio L, et al. Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies. Transfusion. 2025. doi:10.1111/trf.18102
BibTeX
@article{Muret2025,
author = {Muret, Charlotte and Crettaz, David and Martin, Agathe and Aliotta, Alessandro and Bertaggia Calderara, Debora and Alberio, Lorenzo and Prudent, Michel},
title = {Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18102}
}
EUVIMED